Bachem Holding company profile
Company profile
Bachem Holding has 2,725 employees and is headquartered in Bubendorf, Switzerland.
Pharmaceutical and biotech companies around the world rely on Bachem Holding AG, which develops and manufactures peptide active pharmaceutical ingredients. Its portfolio spans peptide and oligonucleotide new chemical entities, commercial new chemical entities and generics. Alongside production, the group provides project management, analytical services, quality and regulatory work, research-grade production and supply services.
In the fiscal year ended 31 December 2025, the group reported revenue of CHF 695.1 million, an increase of 14.8% on the previous year, and net income of CHF 148.8 million. The company has 2,725 employees, and its headquarters are in Bubendorf, Switzerland. It was founded in 1971 and is a subsidiary of Ingro Finanz AG.
Company facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Switzerland
- Headquarters
- Hauptstrasse 144, 4416, Bubendorf
- Employees
- 2,725
- Chief executive
- Anne-Kathrin Stoller
- Founded
- 1971
- Fiscal year
- January - December
- Listing
- BANB · SIX
- Currency
- CHF
- ISIN
- CH1176493729
- Website
- bachem.com
Bachem Holding and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Bachem HoldingBANB | Switzerland | $6.92B | 2,725 | 21.8% | 39.2 |
| ABIVAXABVX | France | $7.61B | 98 | -6,270.4% | — |
| ALK-AbellóALK.B | Denmark | $8.09B | 2,773 | 26.9% | 40.7 |
| CamurusCAMX | Sweden | $4.36B | 323 | 37.4% | 58.5 |
| Financière de TubizeTUB | Belgium | $11.78B | 3 | 0.0% | 109.0 |
| BioArcticBIOA.B | Sweden | $2.72B | 150 | 19.6% | 262.7 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
